scholarly journals Childhood rare lung disease in the 21st century: “‐omics” technology advances accelerating discovery

2020 ◽  
Vol 55 (7) ◽  
pp. 1828-1837
Author(s):  
Timothy J. Vece ◽  
Jennifer A. Wambach ◽  
James S. Hagood
Neonatology ◽  
2000 ◽  
Vol 78 (3) ◽  
pp. 233-268 ◽  
Author(s):  
K.E. Lundstrøm ◽  
N.J. Shaw ◽  
M.A. Thomson

2020 ◽  
Vol 26 (2) ◽  
pp. 135-141 ◽  
Author(s):  
Rachel Leonard ◽  
Rafia Zulfikar ◽  
Robert Stansbury

2021 ◽  
Vol 9 (1) ◽  
pp. 46-47
Author(s):  
M.Athar Ansari ◽  
Ali Jafar Abedi ◽  
M. Salman Shah

Non-communicable diseases (NCDs) are responsible for almost 70% of all deaths worldwide. Almost 75% of all NCD deaths, and 82% of the 16 million people that died prematurely, or before reaching 70 years aged, occur in low and middle-income countries. The epidemic of NCDs including heart condition, stroke, cancer, diabetes, and chronic lung disease poses devastating health consequences for people, and threatens to overburden the health systems. In finances starved countries, the costs associated with NCDs make the management of these diseases a major development concern for the 21st century.[1]


Sign in / Sign up

Export Citation Format

Share Document